DoD Peer Reviewed Medical Technology/Therapeutic Development Award

 

The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, patient care, and/or quality of life, in at least one of the Congressionally directed FY13 PRMRP Topic Areas. Products in development should be responsive to the health care needs of military service members,Veterans, and/or beneficiaries. The product(s) to be developed may be pharmacologic agents (drugs or biologics), devices, and/or clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award.

General information about this opportunity
Last Known Status
Deleted 11/07/2013 (Archived.)
Program Number
W81XWH-13-PRMRP-TTDA
Federal Agency/Office
Agency: Department of Defense
Office: U.S. Army Medical Research Acquisition Activity
Type(s) of Assistance Offered
Cooperative Agreement, Grant
Number of Awards Available
3
What is the process for applying and being award this assistance?
Deadlines
10/08/2013
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Headquarters Office
301-682-5507; help@cdmrp.org
E-mail Address
help@cdmrp.org
Financial Information
Obligations
$6,750,000.00

 


Related Federal Grants


Federal Grants Resources